Tectonic Therapeutic Statistics
Total Valuation
TECX has a market cap or net worth of $510.72 million. The enterprise value is $258.20 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TECX has 18.78 million shares outstanding. The number of shares has increased by 115.81% in one year.
| Current Share Class | 18.78M |
| Shares Outstanding | 18.78M |
| Shares Change (YoY) | +115.81% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 34.25% |
| Owned by Institutions (%) | 77.35% |
| Float | 11.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.03 |
| P/TBV Ratio | 2.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 26.63, with a Debt / Equity ratio of 0.01.
| Current Ratio | 26.63 |
| Quick Ratio | 26.26 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,333.90 |
Financial Efficiency
Return on equity (ROE) is -37.82% and return on invested capital (ROIC) is -26.48%.
| Return on Equity (ROE) | -37.82% |
| Return on Assets (ROA) | -25.38% |
| Return on Invested Capital (ROIC) | -26.48% |
| Return on Capital Employed (ROCE) | -33.43% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.24M |
| Employee Count | 60 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TECX has paid $1.23 million in taxes.
| Income Tax | 1.23M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.97% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +28.97% |
| 50-Day Moving Average | 28.63 |
| 200-Day Moving Average | 22.00 |
| Relative Strength Index (RSI) | 39.68 |
| Average Volume (20 Days) | 204,279 |
Short Selling Information
The latest short interest is 2.43 million, so 12.92% of the outstanding shares have been sold short.
| Short Interest | 2.43M |
| Short Previous Month | 2.41M |
| Short % of Shares Out | 12.92% |
| Short % of Float | 21.70% |
| Short Ratio (days to cover) | 12.92 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -84.04M |
| Pretax Income | -72.92M |
| Net Income | -74.15M |
| EBITDA | -82.66M |
| EBIT | -84.04M |
| Earnings Per Share (EPS) | -$4.05 |
Full Income StatementBalance Sheet
The company has $253.80 million in cash and $1.28 million in debt, giving a net cash position of $252.52 million or $13.45 per share.
| Cash & Cash Equivalents | 253.80M |
| Total Debt | 1.28M |
| Net Cash | 252.52M |
| Net Cash Per Share | $13.45 |
| Equity (Book Value) | 251.33M |
| Book Value Per Share | 13.41 |
| Working Capital | 247.69M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$60.08 million and capital expenditures -$208,000, giving a free cash flow of -$60.29 million.
| Operating Cash Flow | -60.08M |
| Capital Expenditures | -208,000 |
| Depreciation & Amortization | 1.38M |
| Net Borrowing | -489,000 |
| Free Cash Flow | -60.29M |
| FCF Per Share | -$3.21 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |